A simple letter changed how doctors ordered blood tests
Across Australia, a four-page letter quietly reshaped the habits of the country's highest-ordering general practitioners — not through mandate or penalty, but through the simple act of holding up a mirror. A Federal Government-funded study found that GPs shown how their pathology test ordering compared to peers reduced those requests by 36 percent, eliminating roughly 42,000 unnecessary tests a year without any measurable harm to patients. The finding speaks to something enduring about professional identity: that the awareness of how one stands among one's peers can move behaviour where rules and restrictions cannot.
- Unnecessary pathology testing quietly drains healthcare resources and exposes patients to cascading false positives — yet blunt restrictions risk missing genuine clinical need.
- A deceptively simple intervention — a four-page letter telling high-volume GPs they sat in the 90th percentile for test ordering — triggered a 36% reduction in targeted pathology requests over six months.
- The study targeted the top 10% of orderers across ten common test batteries, including iron studies, vitamin D, TSH, and B12 — the reflexive staples of everyday general practice.
- Critically, no clinical harm was detected: the reduction appears to represent genuine over-ordering corrected, not necessary care withheld.
- The intervention now sits at a policy crossroads — whether it becomes a scalable, standing tool or fades as a one-off result depends on whether its behavioural effect holds over time.
A four-page letter, printed on official letterhead and sent to general practitioners across Australia, turned out to carry unusual weight. It contained no directive, no threat of audit — only a single comparison: the recipient's pathology ordering rates placed them in the top 10 percent of their peers. That information alone was enough to change behaviour.
The Federal Government-funded study tracked GPs who were high-volume orderers of ten common test batteries — combinations built around iron studies, thyroid-stimulating hormone, vitamin D, and B12. These are the routine, often reflexive investigations of general practice. The GPs who received the nudge letters reduced their ordering of the targeted tests by 36 percent over the following six months, translating to approximately 42,000 fewer pathology requests annually across the country.
What makes the finding significant is its ethical and practical simplicity. The participants did not know they were in a study. They were given information about their own practice patterns relative to peers, and left to draw their own conclusions. The result suggests that professional awareness — the quiet discomfort of seeing oneself as an outlier — can prompt genuine reflection and self-correction.
Unlike blanket restrictions, which risk denying necessary care, or bureaucratic gatekeeping, which burdens clinicians, the nudge approach respects autonomy while making visible what was previously invisible. Unnecessary testing is a real cost: financially, in laboratory capacity, and in the patient anxiety that follows false positives. This research points toward a middle path.
The open question is durability. Whether a single letter produces lasting change in how practitioners think about ordering — or only a temporary correction — will determine whether this becomes a standard instrument of healthcare policy or remains a compelling but isolated experiment.
A simple letter arrived in the mailboxes of general practitioners across Australia, and it changed how they ordered blood tests. The letter was unremarkable on its face—four pages, printed on official letterhead—but it contained a single piece of information that proved remarkably effective: a comparison showing that the recipient's practice was ordering certain pathology tests far more frequently than their peers.
The study, funded by the Federal Government, tracked what happened next. GPs who received these 'nudge letters' cut back on their ordering of the targeted tests by 36 percent over the following six months. Scaled across the country, that reduction translated to approximately 42,000 fewer pathology requests annually—a substantial decrease achieved not through regulation or restriction, but through a quiet appeal to professional awareness.
The research focused on ten common test batteries, each a combination of the same handful of investigations: iron studies, thyroid-stimulating hormone, vitamin D, vitamin B12, and thyroid function tests. These are the workhorses of general practice pathology, ordered routinely and often reflexively. The GPs who received letters were those in the top 10 percent for ordering these particular batteries, and who also ranked in the top 10 percent for at least two of the five individual tests during 2020 and 2021. In other words, they were the high-volume orderers, the practices whose request patterns stood out against the broader population.
What makes the intervention notable is its simplicity and its ethical clarity. The GPs did not know they were participating in a study. They received a letter telling them where they stood relative to their peers—that they were in the 90th percentile for ordering—and nothing more. No directive. No threat of audit or sanction. Just information, delivered plainly, about their own practice patterns.
The result suggests something important about how doctors make decisions. The comparison to peers appears to have prompted reflection. Some of those high-volume orderers may have reconsidered whether every test was truly necessary. Others may have tightened their criteria for ordering. The net effect was a substantial reduction in testing without, according to the research, compromising patient care or clinical outcomes.
This approach sits at the intersection of behavioral economics and healthcare policy. Rather than imposing top-down restrictions on what tests GPs can order, or creating bureaucratic barriers to pathology requests, the nudge letter works by making visible what was previously invisible: how one's practice compares to others. It appeals to professional standards and peer norms rather than to fear or punishment.
The study's findings matter because unnecessary pathology testing is a genuine problem in healthcare systems worldwide. Tests cost money, consume laboratory resources, and can generate false positives that lead to further unnecessary investigation and patient anxiety. Yet reducing testing without losing sight of genuine clinical need is difficult. Blanket restrictions risk harm. This research suggests a middle path: a low-cost, scalable intervention that respects clinician autonomy while providing the information needed to self-correct.
The question now is whether this approach will be adopted more broadly, and whether the effect persists over time. A single intervention might produce a temporary shift in behavior, or it might prompt lasting change in how practitioners think about their ordering patterns. The answer will determine whether this becomes a standard tool in the healthcare administrator's toolkit, or remains a promising one-off study.
Citações Notáveis
GPs who received letters showing they were in the 90th percentile for ordering particular tests reduced orders for those tests by 36% in the next six months— Federal Government-funded study findings
A Conversa do Hearth Outra perspectiva sobre a história
Why did the letters work? What made GPs actually change their behavior?
The comparison to peers seems to have been the key. Doctors don't typically see how their ordering patterns stack up against others. When they learned they were in the 90th percentile, it created a moment of reflection—a chance to ask whether every test was truly necessary.
But couldn't that just be a Hawthorne effect? Once they knew they were being watched, they changed behavior temporarily?
That's the real question. The study showed a 36 percent reduction over six months, but we don't yet know if that holds at a year, or two years. Behavioral nudges can fade. What matters is whether this prompts lasting change in how doctors think about ordering.
Forty-two thousand fewer tests a year—that's a lot of pathology not happening. Are we sure nothing was missed?
The research suggests clinical outcomes didn't suffer, but that's the crucial thing to watch. You can reduce unnecessary testing, but you have to be certain you're not creating blind spots. The tests they targeted—iron studies, vitamin D, B12—are areas where overordering is genuinely common. The nudge seems to have trimmed excess without cutting into necessary care.
Why not just tell GPs directly: stop ordering so many tests?
Because that doesn't work. Doctors resist mandates. They have reasons for what they do, even if those reasons aren't always sound. A letter comparing you to peers is gentler. It invites self-reflection rather than demanding compliance. It respects autonomy while providing information.
Who benefits most from this? The health system saves money, but what about patients?
Patients benefit from fewer unnecessary tests—less anxiety about false positives, less cascade of follow-up investigations that weren't needed. But the real beneficiary is the system itself. This is scalable and cheap. You don't need new infrastructure or new rules. You just need data and a printer.